|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.73 USD | +1.60% |
|
-0.29% | -3.96% |
| 05-13 | Supernus Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:40 PM | |
| 05-05 | Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.60% | -0.29% | +1.90% | -1.97% | -3.96% | +42.86% | +56.90% | +70.34% | +111.85% | 2.77B | |
| +0.81% | +4.40% | +2.46% | +19.80% | +25.23% | +56.82% | +23.96% | +68.29% | +125.60% | 326B | |
| +2.41% | +6.16% | +11.32% | +30.67% | +23.99% | +44.54% | +91.12% | +100.54% | +754.09% | 9.9B | |
| +1.73% | +2.82% | +4.79% | +14.35% | +6.89% | +4.57% | -0.55% | -26.00% | +49.81% | 8.49B | |
| -2.93% | +2.45% | -4.10% | -22.51% | -36.20% | -20.66% | -2.69% | -33.75% | - | 4.28B | |
| -3.73% | -3.89% | +0.43% | +17.39% | +24.50% | -9.31% | +1.86% | -33.27% | - | 3.61B | |
| -1.81% | +1.58% | +6.48% | -24.55% | -37.10% | -41.23% | +7.12% | +32.65% | +77.65% | 3.63B | |
| -0.87% | -4.54% | +2.80% | -18.56% | -18.10% | -7.97% | -10.77% | +73.91% | - | 2.1B | |
| -5.16% | -6.21% | +13.49% | -7.96% | -6.98% | -20.06% | +18.69% | -31.29% | - | 1.78B | |
| -0.58% | -1.15% | +10.67% | -9.94% | -14.75% | -23.40% | -21.01% | -6.31% | -43.06% | 1.71B | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64B | |
| -6.11% | +3.64% | +2.34% | -38.69% | -36.85% | +47.03% | +43.51% | +27.20% | +472.82% | 1.2B | |
| +10.28% | +8.01% | +30.70% | +93.13% | +175.93% | +210.45% | +1,729.80% | +739.21% | - | 1.28B | |
| -5.90% | -4.51% | -0.82% | -9.49% | +7.81% | -4.75% | +76.43% | +12.29% | - | 1.08B | |
| -2.37% | -8.29% | -5.84% | -31.33% | -22.13% | -38.92% | -33.71% | - | - | 1.11B | |
| +2.71% | +3.94% | +5.58% | -0.46% | -6.34% | +1.16% | +44.68% | +92.53% | +84.77% | 1.07B | |
| +0.28% | -1.24% | +5.96% | -20.67% | -23.70% | -39.18% | -77.07% | -81.76% | - | 879M | |
| +1.27% | -0.83% | 0.00% | -13.77% | -14.39% | -45.03% | -14.08% | -46.03% | -66.57% | 850M | |
| -4.27% | +0.33% | -13.94% | -43.88% | -33.08% | -6.92% | -5.32% | -10.77% | +132.69% | 795M | |
| -2.79% | -4.12% | -17.47% | -34.33% | -29.82% | +38.55% | -21.56% | -75.80% | -96.16% | 800M | |
| Average | -0.82% | +0.09% | +2.99% | -5.41% | -1.00% | +9.92% | +100.38% | +48.44% | +145.77% | 18.73B | |
| Weighted average by Cap. | +0.68% | +4.56% | +2.77% | +17.73% | +22.25% | +50.86% | +29.78% | +64.70% | +139.94% |
- Stock Market
- Stocks
- SUPN Stock
- Sector Supernus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
